Stocks · Consumer Defensive · Packaged Foods
USANA Health Sciences, Inc. USNA
$14.82 +3.13% Close, Oct 2, 2026 · NYSE · Market cap $273.6M
Next earnings report: Oct 28, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $-1.21, down 167.1% year over year.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
- Over the past year the stock returned -45.7%, behind the S&P 500 by 60.7 percentage points.
PromtFinance scores
Each score is a percentile within the Consumer Defensive sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 36%
- EPS growth (TTM, YoY)Bottom 10%
- FCF growth (TTM, YoY)Bottom 13%
- Revenue growth, 3-year CAGRBottom 19%
- Revenue growth accelerationBottom 11%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 3%
- Gross marginTop 2%
- Operating marginBottom 24%
- Accruals (lower is better)Top 39%
- Net debt / EBITDA (lower is better)Top 3%
- Interest coverTop 17%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 19%
- Free-cash-flow yieldBottom 50%
- EBITDA / enterprise valueTop 2%
- Sales / enterprise valueTop 2%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 9%
- 6-month returnBottom 40%
- 1-year return vs S&P 500Bottom 13%
- Distance from 52-week highBottom 19%
- Trend checklist (0–4)Top 44%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 9%
- Consecutive EPS beatsBottom 15%
- Share of analysts rating BuyBottom 16%
- Upside to consensus price targetTop 7%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 4%
- Maximum drawdown, 3 yearsBottom 13%
- Beta vs S&P 500 (lower is better)Bottom 21%
- Net debt / EBITDA (lower is better)Top 3%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 5.7% | 1.6% | ↓ |
| EPS growth (YoY) | -74.0% | -167.1% | ↓ |
| Gross margin | 77.3% | 77.4% | ↑ |
| Operating margin | 6.2% | 1.4% | ↓ |
| FCF margin | 5.7% | 1.7% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 1.6% | 5.7% | ↓ | Bottom 36% |
| EPS growth (TTM, YoY) | -167.1% | -74.0% | ↓ | Bottom 10% |
| Gross margin | 77.4% | 77.3% | ↑ | Top 2% |
| Operating margin | 1.4% | 6.2% | ↓ | Bottom 24% |
| Net margin | -2.4% | 3.8% | ↓ | — |
| Free-cash-flow margin | 1.7% | 5.7% | ↓ | — |
| Return on invested capital | -23.8% | — | Bottom 3% | |
| Revenue growth, 3-year CAGR | -2.5% | — | Bottom 19% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -7.1%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.2%
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- -5.17×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 30.0×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 0.00%
- Shareholder yield
- 0.00%
- Share count change, 1 year
- -0.3%
- Share count change, 3-year CAGR
- -1.6%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jul 4, 2026 (filed Aug 13, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 6 of 8
- Average EPS surprise, last 4
- -47.8%
- Average 2-day reaction, last 8
- +0.8%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $35.00
- Target vs current price
- +136.2%
- Analysts with a rating
- 8
- Share rating Buy or Strong Buy
- 25%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 4, 2026 | -116.3% | -0.3% | -37.2% | -37.6% | — |
| May 5, 2026 | +38.6% | +3.8% | -6.1% | -2.7% | +19.5% |
| Feb 17, 2026 | +46.3% | -1.1% | +4.4% | -16.1% | -16.9% |
| Oct 21, 2025 | -160.0% | +1.7% | -2.8% | -8.5% | +4.4% |
| Jul 22, 2025 | +37.0% | +4.1% | +3.8% | +0.1% | -30.0% |
| Apr 22, 2025 | +4.3% | +1.7% | +15.6% | +26.2% | +28.5% |
| Feb 25, 2025 | +30.6% | -2.2% | -8.3% | -16.7% | -8.1% |
| Oct 22, 2024 | +14.3% | -1.6% | +6.4% | +12.4% | -2.9% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | -$0.07 | $0.43 | -116.3% | $223.3M |
| May 5, 2026 | $0.61 | $0.44 | +38.6% | $250.0M |
| Feb 17, 2026 | $0.60 | $0.41 | +46.3% | $226.2M |
| Oct 21, 2025 | -$0.15 | $0.25 | -160.0% | $213.7M |
| Jul 22, 2025 | $0.74 | $0.54 | +37.0% | $235.8M |
| Apr 22, 2025 | $0.73 | $0.70 | +4.3% | $249.5M |
| Feb 25, 2025 | $0.64 | $0.49 | +30.6% | $213.6M |
| Oct 22, 2024 | $0.56 | $0.49 | +14.3% | $200.2M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (forward) | 19.5× | — | — | — |
| EV / EBITDA | 3.2× | — | — | Top 2% |
| EV / Sales | 0.12× | — | — | Top 2% |
| Free-cash-flow yield | 5.82% | — | — | Bottom 50% |
| Earnings yield | -8.14% | — | — | Bottom 19% |
P/E over the past five years
Range 12.9× – 36.7× since Jul 3, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -45.7%
- Earnings per share growth (TTM)
- -167.1%
- Change in P/E multiple
- +134.7%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -15.2%
- 200-day average slope (20 days)
- -2.6%
- Distance from 50-day average
- -5.0%
- Distance from 200-day average
- -20.4%
- RSI (14)
- 50.1
- Relative volume
- 0.62×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 95.5%
- Volatility vs own 5-year history
- 97th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.87
- Correlation with S&P 500
- 0.28
- Current drawdown from 1-year high
- -46.0%
- Maximum drawdown, 3 years
- -78.2%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jun 1, 2021 | Aug 17, 2026 | -87.9% | 1308 days | Not yet recovered |
| Oct 23, 2020 | Nov 18, 2020 | -14.1% | 18 days | 43 days (Jan 22, 2021) |
| Apr 15, 2021 | Apr 28, 2021 | -12.5% | 9 days | 16 days (May 20, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $273.6M
- EPS, diluted (TTM)
- -$1.21
- Revenue (TTM)
- $913.4M
- 52-week range
- $12.57 – $27.95
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $1.19B | $998.6M | $921.0M | $854.5M | $925.3M |
| Gross profit | $955.5M | $791.3M | $731.6M | $678.8M | $724.4M |
| Operating income | $170.2M | $107.6M | $93.1M | $66.3M | $50.9M |
| Net income | $116.5M | $69.3M | $63.8M | $42.0M | $10.8M |
| EPS (diluted) | $5.73 | $3.59 | $3.30 | $2.19 | $0.58 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $200.2M | $213.6M | $249.5M | $235.8M | $213.7M | $226.2M | $250.2M | $223.3M |
| Net income | $10.6M | $4.5M | $9.4M | $9.7M | -$6.5M | -$1.8M | $7.5M | -$21.4M |
| EPS (diluted) | $0.56 | $0.23 | $0.49 | $0.52 | -$0.36 | -$0.10 | $0.41 | -$1.16 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $121.2M | $103.9M | $70.6M | $61.0M | $22.3M |
| Capital expenditure | -$12.8M | -$10.4M | -$14.5M | -$10.1M | -$13.8M |
| Free cash flow | $108.5M | $93.5M | $56.1M | $50.9M | $8.5M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$177.8M | -$25.4M | -$11.6M | -$9.4M | -$27.5M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $168.6M
- Total assets
- $703.2M
- Total liabilities
- $132.2M
- Total debt
- $0
- Net debt
- -$168.6M
- Shareholders’ equity
- $526.3M
As of Jul 4, 2026 (filed Aug 13, 2026).
Short interest
- Shares sold short
- 754,694
- Days to cover
- 3.36
- Change vs previous report
- +16.9%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Nov 23, 2016
- 2-for-1
- Oct 31, 2003
- 2-for-1
- Aug 4, 1998
- 2-for-1